Skip to main content

Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs

Increased interest in the mRNA technology used to make Covid vaccines has driven a lot of capital into biotech stocks, fueling record financings and IPOs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.